VC-backed Alcresta Therapeutics taps Weiner as CCO

Alcresta Therapeutics, a developer of enzyme-based products, has named Jason Weiner as chief commercial officer.

27 July 2020•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Human Resources Briefs